Reported Q: Q1 2025 Rev YoY: +1.1% EPS YoY: +139.5% Move: -1.13%
Safilo Group SpA
0NJ5.L
€2.05 -1.13%
Exchange LSE Sector Healthcare Industry Medical Instruments Supplies
Q1 2025
Published: Mar 31, 2025

Company Status Snapshot

Fast view of the latest quarter outcome for 0NJ5.L

Reported

Report Date

Mar 31, 2025

Quarter Q1 2025

Revenue

268.81M

YoY: +1.1%

EPS

0.05

YoY: +139.5%

Market Move

-1.13%

Previous quarter: Q4 2024

Follow this company to get upcoming quarter alerts automatically.

Earnings Highlights

  • Revenue of $268.81M up 1.1% year-over-year
  • EPS of $0.05 increased by 139.5% from previous year
  • Gross margin of 61.1%
  • Net income of 20.86M
  • "N/A" - N/A
0NJ5.L
Company 0NJ5.L

Executive Summary

Safilo Group S.p.A. reported a solid year-over-year improvement in profitability for QQ1 2025, but experienced a pronounced quarter-over-quarter revenue decline consistent with seasonality in the eyewear cycle. Revenue reached EUR 268.8 million, up 1.07% from QQ1 2024, while QoQ revenue dropped 41.72% versus the prior quarter (Q4 2024). The company posted gross profit of EUR 164.1 million and a gross margin of 61.05%, indicating strong product pricing and mix discipline despite weaker topline momentum. EBITDA stood at EUR 32.66 million (12.15% of revenue), and operating income was EUR 25.64 million (9.54% margin). Net income was EUR 20.86 million, delivering a net margin of 7.76% and EPS of EUR 0.050 (diluted EUR 0.050). The YoY improvement in profitability is notable (net income up 136.9% YoY; EPS up ~139.5%), suggesting some benefit from fixed-cost absorption, operating leverage, and potential mix effects, even as near-term demand shows volatility.

Key drivers include a favorable gross margin, disciplined cost management, and a diversified brand portfolio with exposure to owned and licensed names. However, the quarter’s sharp sequential revenue decline underscores seasonality and potential channel mix challenges that may pressure quarterly comparability. There is no forward guidance provided in the disclosed materials, limiting visibility into cadence of a rebound. Investors should monitor brand performance, geographic mix, licensing contributions, and any changes in working capital or capital expenditure as the company progresses through the year.

Key Performance Indicators

Revenue
Increasing
268.81M
QoQ: -41.72% | YoY: 1.07%
Gross Profit
Increasing
164.12M
61.05% margin
QoQ: -36.43% | YoY: 2.84%
Operating Income
Increasing
25.64M
QoQ: 127.79% | YoY: 67.72%
Net Income
Increasing
20.86M
QoQ: 344.67% | YoY: 136.91%
EPS
Increasing
0.05
QoQ: 333.62% | YoY: 139.52%

Revenue Trend

Margin Analysis

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q2 2025 268.81 0.05 +133.1% View
Q1 2025 268.81 0.05 +1.1% View
Q4 2024 461.26 0.01 -2.8% View
Q3 2024 230.63 0.01 -2.8% View